Drug Shortage Report for IXCHIQ
| Report ID | 272806 |
| Drug Identification Number | 02548984 |
| Brand name | IXCHIQ |
| Common or Proper name | Chikungunya Vaccine, live, attenuated |
| Company Name | VALNEVA AUSTRIA GMBH |
| Market Status | MARKETED |
| Active Ingredient(s) | CHIKUNGUNYA VIRUS LIVE-ATTENUATED |
| Strength(s) | 3Log10 TCID50 |
| Dosage form(s) | POWDER FOR SOLUTION |
| Route of administration | INTRAMUSCULAR |
| Packaging size | 1 dose |
| ATC code | J07BX |
| ATC description | |
| Reason for shortage | Demand increase for the drug. |
| Anticipated start date | |
| Actual start date | 2025-11-28 |
| Estimated end date | 2026-01-31 |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2025-11-29 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | CAMPUS VIENNA BIOCENTER 3 VIENNA, WIEN AUSTRIA 1030 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v4 | 2025-11-29 | English | Compare |
| v3 | 2025-11-28 | French | Compare |
| v2 | 2025-11-28 | English | Compare |
| v1 | 2025-11-28 | English | Compare |
Showing 1 to 4 of 4